Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$106.4 - $157.19 $10,640 - $15,719
-100 Reduced 4.17%
2,300 $263,000
Q1 2023

May 02, 2023

BUY
$117.53 - $155.99 $282,072 - $374,376
2,400 New
2,400 $330,000
Q1 2019

Apr 08, 2019

SELL
$106.67 - $151.68 $533,350 - $758,400
-5,000 Closed
0 $0
Q3 2018

Oct 04, 2018

BUY
$115.31 - $161.51 $576,550 - $807,550
5,000 New
5,000 $541,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.